Observation on the Interventional Effect of Improved Moxibustion on Turtle Shell and Balanced Cupping Therapy on Patients with Primary Dysmenorrhea

注册号:

Registration number:

ITMCTR2025000677

最近更新日期:

Date of Last Refreshed on:

2025-04-07

注册时间:

Date of Registration:

2025-04-07

注册号状态:

Registration Status:

补注册

Retrospective registration

注册题目:

改良推熨鳖甲灸联合平衡火罐技术对原发性痛经患者的干预效果观察

Public title:

Observation on the Interventional Effect of Improved Moxibustion on Turtle Shell and Balanced Cupping Therapy on Patients with Primary Dysmenorrhea

注册题目简写:

English Acronym:

研究课题的正式科学名称:

改良推熨鳖甲灸联合平衡火罐技术对原发性痛经患者的干预效果观察

Scientific title:

Observation on the Interventional Effect of Improved Moxibustion on Turtle Shell and Balanced Cupping Therapy on Patients with Primary Dysmenorrhea

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

金莉莎

研究负责人:

张晓雪

Applicant:

Jin Lisha

Study leader:

Zhang Xiaoxue

申请注册联系人电话:

Applicant telephone:

18652932403

研究负责人电话:

Study leader's telephone:

18951755357

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

491254684@qq.com

研究负责人电子邮件:

Study leader's E-mail:

157860199@qq.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

中国江苏省南京市秦淮区大明路157号

研究负责人通讯地址:

中国江苏省南京市秦淮区大明路157号

Applicant address:

No.157 Daming Road Qinhuai District Nanjing City Jiangsu Province China

Study leader's address:

No.157 Daming Road Qinhuai District Nanjing City Jiangsu Province China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

南京市中医院

Applicant's institution:

Nanjing Hospital of Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

KY2024058

伦理委员会批件附件:

Approved file of Ethical Committee:

View

批准本研究的伦理委员会名称:

南京市中医院伦理委员会

Name of the ethic committee:

Nanjing Hospital of Chinese Medicine Ethics Committee

伦理委员会批准日期:

Date of approved by ethic committee:

2024/8/1 0:00:00

伦理委员会联系人:

刘峥

Contact Name of the ethic committee:

Liu zheng

伦理委员会联系地址:

中国江苏省南京市秦淮区大明路157号

Contact Address of the ethic committee:

No.157 Daming Road Qinhuai District Nanjing City Jiangsu Province China

伦理委员会联系人电话:

Contact phone of the ethic committee:

025-52276505

伦理委员会联系人邮箱:

Contact email of the ethic committee:

njszyyll@163.com

研究实施负责(组长)单位:

南京市中医院

Primary sponsor:

Nanjing Hospital of Chinese Medicine

研究实施负责(组长)单位地址:

中国江苏省南京市秦淮区大明路157号

Primary sponsor's address:

No.157 Daming Road Qinhuai District Nanjing City Jiangsu Province China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

江苏省

市(区县):

南京市

Country:

China

Province:

Jiangsu

City:

Nanjing

单位(医院):

南京市中医院

具体地址:

中国江苏省南京市秦淮区大明路157号

Institution
hospital:

Nanjing Hospital of Chinese Medicine

Address:

No.157 Daming Road Qinhuai District Nanjing City Jiangsu Province China

经费或物资来源:

南京市中医院科研基金资助项目

Source(s) of funding:

Nanjing Hospital of Chinese Medicine Research Fund

研究疾病:

原发性痛经

研究疾病代码:

SB96

Target disease:

Primary dysmenorrhea

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

探索性研究/预试验

Pilot clinical trial

研究目的:

通过本研究,探讨改良推熨鳖甲灸联合平衡火罐技术干预原发性痛经的可行性,期望为临床护理原发性痛经患者找到更加安全、有效、简便、舒适度高的方法。拓展鳖甲灸技术的临床应用范围,丰富中医药内病外治的内涵,体现和发挥中医护理适宜技术优势。

Objectives of Study:

Through this study, we explore the feasibility of using improved turtle shell moxibustion combined with balanced cupping therapy to intervene in primary dysmenorrhea, with the hope of finding a safer, more effective, simpler, and more comfortable method for clinical nursing of patients with primary dysmenorrhea. This expands the clinical application scope of turtle shell moxibustion technology, enriches the connotation of external treatment for internal diseases in traditional Chinese medicine, and demonstrates and leverages the advantages of appropriate traditional Chinese medicine nursing techniques.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

1.符合原发性痛经诊断标准,出现痛经症状或伴随症状至少3个月经周期。 2.年龄在 11~45 周岁的女性。 3.依从性好,能够配合采集临床资料及愿意接受本疗法患者。 4. 不合并其他内外科疾病者。 5.治疗前3个月未接受过其他相关治疗,患者自愿签署知情同意书。

Inclusion criteria

1.Meets the diagnostic criteria for primary dysmenorrhea with symptoms of dysmenorrhea or associated symptoms occurring for at least 3 menstrual cycles. 2. Female aged between 11 to 45 years old. 3. Good compliance able to cooperate with the collection of clinical data and willing to accept this therapy. 4. Not complicated with other internal or surgical diseases. 5.Has not received other related treatments in the 3 months prior to treatment and the patient voluntarily signs an informed consent form..

排除标准:

1.不符合上述中、西医诊断标准。 2.年龄小于11周岁或大于45周岁者。 3.经检查证实,有盆腔炎等器质性病变所致的痛经患者。 4.伴有严重的心脑血管等疾病及伴有其他可危及生命的原发性疾病的患者。 5.患有精神类疾病,感染性疾病,患有皮肤病、皮肤有破损、有皮疹者,或其他不适宜治疗者。 6.同时接受其它治疗的患者。

Exclusion criteria:

1. Does not meet the diagnostic criteria of traditional Chinese or Western medicine. 2. Patients under 11 years of age or over 45 years of age. 3.Patients with dysmenorrhea caused by organic lesions such as pelvic inflammatory disease confirmed by examination. 4. Patients with severe cardiovascular and cerebrovascular diseases and other primary diseases that may endanger life. 5.Patients with mental illnesses infectious diseases skin diseases skin damage rashes or other conditions that are not suitable for treatment. 6.Patients who are receiving other treatments simultaneously..

研究实施时间:

Study execute time:

From 2024-11-01

To      2025-04-30

征募观察对象时间:

Recruiting time:

From 2024-11-01

To      2025-04-30

干预措施:

Interventions:

组别:

罐法灸法组(观察A组)

样本量:

30

Group:

Cupping and moxibustion group (Observation Group A)

Sample size:

干预措施:

平衡火罐联合改良鳖甲灸

干预措施代码:

Intervention:

Cupping therapy

Intervention code:

组别:

灸法组(观察B组)

样本量:

30

Group:

Moxibustion group (Observation Group B)

Sample size:

干预措施:

改良鳖甲灸

干预措施代码:

Intervention:

Modified Turtle Shell Moxibustion

Intervention code:

组别:

罐法组(对照组)

样本量:

30

Group:

Balanced cupping set (control group)

Sample size:

干预措施:

平衡火罐

干预措施代码:

Intervention:

Balanced cupping

Intervention code:

样本总量 Total sample size : 90

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

江苏省

市(区县):

南京市

Country:

China

Province:

Jiangsu Province

City:

Nanjing City

单位(医院):

南京市中医院

单位级别:

市级

Institution/hospital:

Nanjing Hospital of Chinese Medicine

Level of the institution:

city level

测量指标:

Outcomes:

指标中文名:

人前列腺素E2

指标类型:

次要指标

Outcome:

PGE2

Type:

Secondary indicator

测量时间点:

干预前及干预后

测量方法:

酶联免疫法

Measure time point of outcome:

Before and after intervention

Measure method:

Enzyme-linked immunosorbent assay

指标中文名:

疼痛视觉模拟评分法(VAS)

指标类型:

主要指标

Outcome:

Visual Analogue Scale (VAS)

Type:

Primary indicator

测量时间点:

干预前及干预后

测量方法:

疼痛量表

Measure time point of outcome:

Before intervention and after intervention

Measure method:

Pain Scale

指标中文名:

COX痛经症状量表

指标类型:

主要指标

Outcome:

COX dysmenorrhea symptom scale

Type:

Primary indicator

测量时间点:

干预前及干预后

测量方法:

COX 痛经症状量表

Measure time point of outcome:

Before and after intervention

Measure method:

COX dysmenorrhea symptom scale

指标中文名:

痛经症状评分标准

指标类型:

主要指标

Outcome:

Menstrual cramp symptom scoring criteria

Type:

Primary indicator

测量时间点:

干预前及干预后

测量方法:

痛经症状评分量表

Measure time point of outcome:

Before and after intervention

Measure method:

Menstrual Pain Symptom Rating Scale

指标中文名:

人前列腺素F2α

指标类型:

次要指标

Outcome:

PGF2α

Type:

Secondary indicator

测量时间点:

干预前及干预后

测量方法:

酶联免疫法

Measure time point of outcome:

Before and after intervention

Measure method:

Enzyme-linked immunosorbent assay

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

blood

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

征募研究对象情况:

正在进行

Recruiting

年龄范围:

最小 11
Min age years
最大 45
Max age years

Recruiting status:

Participant age:

性别:

Gender:

女性

Female

随机方法(请说明由何人用什么方法产生随机序列):

由研究者根据每位患者的就诊顺序为初始编号 1-90,用Excel 软件中的 RANDBETWEEN 函数生成范围在 1-90 的 90 个随机不重复的整数,按照数字的大小升序排名,第 1-30、31-60、61-90 名分别为对照组、试验1组、试验2组。

Randomization Procedure (please state who generates the random number sequence and by what method):

Researchers assigned an initial number from 1 to 90 to each patient based on their order of visit. Using the RANDBETWEEN function in Excel software, 90 unique random integers within the range of 1 to 90 were generated. These numbers were then ranked in ascending order, with the first 30 numbers assigned to the control group, the next 30 numbers to the experimental group 1, and the last 30 numbers to the experimental group 2.

盲法:

Blinding:

是否共享原始数据:

IPD sharing:

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

不公开

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

no public

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form CRF

数据管理委员会:

Data Managemen Committee:

暂未确定

Not yet

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above